105 related articles for article (PubMed ID: 6694625)
1. A pilot study of flutamide. A new agent in the treatment of advanced prostatic cancer.
Sarfaty GA; Alder SJ; McLean RG
Med J Aust; 1984 Feb; 140(4):219-21. PubMed ID: 6694625
[TBL] [Abstract][Full Text] [Related]
2. The use of flutamide as monotherapy in the treatment of advanced prostate cancer.
Newling DW
Prog Clin Biol Res; 1989; 303():117-21. PubMed ID: 2674980
[No Abstract] [Full Text] [Related]
3. 'Zoladex' versus 'Zoladex' plus flutamide in the treatment of advanced prostate cancer. First interim analysis of an international trial. International Prostate Cancer Study Group.
Lunglmayr G
Prog Clin Biol Res; 1989; 303():145-51. PubMed ID: 2528737
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced prostatic cancer with flutamide.
Sanford EJ; Bowditch RR; Rohner TJ; Bardin CW
Pa Med; 1979 Sep; 82(9):29-31. PubMed ID: 386212
[No Abstract] [Full Text] [Related]
5. Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer.
Nishimura K; Arichi N; Tokugawa S; Yoshioka I; Kishikawa H; Ichikawa Y
Int J Urol; 2007 Mar; 14(3):264-7. PubMed ID: 17430272
[TBL] [Abstract][Full Text] [Related]
6. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
[TBL] [Abstract][Full Text] [Related]
7. A new antiprostatic agent for treatment of prostatic carcinoma.
Irwin RJ; Prout GR
Surg Forum; 1973; 24():536-7. PubMed ID: 4806089
[No Abstract] [Full Text] [Related]
8. Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer.
Miyake H; Hara I; Eto H
BJU Int; 2005 Oct; 96(6):791-5. PubMed ID: 16153202
[TBL] [Abstract][Full Text] [Related]
9. [Lack of effect of therapy with LHRH analogs, alone or associated with flutamide, on prolactin levels in advanced prostatic carcinoma].
Banchini A; Zavaroni D; Tarditi E; Cortellini P; Ziveri M; Polotti R; Stefani F; Valenti G
Minerva Endocrinol; 1989; 14(3):165-8. PubMed ID: 2533662
[TBL] [Abstract][Full Text] [Related]
10. Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?
Ramsey S; Veenstra D; Clarke L; Gandhi S; Hirsch M; Penson D
Urology; 2005 Oct; 66(4):835-9. PubMed ID: 16230148
[TBL] [Abstract][Full Text] [Related]
11. Flutamide approved for prostate cancer.
Oncology (Williston Park); 1989 Mar; 3(3):135. PubMed ID: 2518157
[No Abstract] [Full Text] [Related]
12. A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapy.
Davis NB; Ryan CW; Stadler WM; Vogelzang NJ
BJU Int; 2005 Oct; 96(6):787-90. PubMed ID: 16153201
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with flutamide and castration: its benefits at various stages of prostate cancer.
Labrie F; Dupont A; Cusan L; Manhès G; Bergeron N; Lacourcière Y; Pineault S; Bélanger A; Monfette G; Emond J
Prog Clin Biol Res; 1989; 303():161-7. PubMed ID: 2674982
[No Abstract] [Full Text] [Related]
14. Flutamide therapy for advanced prostatic cancer: a phase II study.
MacFarlane JR; Tolley DA
Br J Urol; 1985 Apr; 57(2):172-4. PubMed ID: 3986452
[TBL] [Abstract][Full Text] [Related]
15. Bicalutamide: a new antiandrogen for use in combination with castration for patients with advanced prostate cancer.
Blackledge G; Kolvenbag G; Nash A
Anticancer Drugs; 1996 Jan; 7(1):27-34. PubMed ID: 8742095
[TBL] [Abstract][Full Text] [Related]
16. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
Boccon-Gibod L; Fournier G; Bottet P; Marechal JM; Guiter J; Rischman P; Hubert J; Soret JY; Mangin P; Mallo C; Fraysse CE
Eur Urol; 1997; 32(4):391-5; discussion 395-6. PubMed ID: 9412794
[TBL] [Abstract][Full Text] [Related]
17. Re: The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.
Gardiner RA; Nicol DL; Green HJ; Yaxley J; Watson R; Mactaggart P; Headley BC; Swanson C; Pakenham KI
J Urol; 2004 Aug; 172(2):774; author reply 774-5. PubMed ID: 15247782
[No Abstract] [Full Text] [Related]
18. [Flutamide in the treatment of advanced carcinoma of the prostate].
Vomácka V; Vachalovský V
Rozhl Chir; 1985 Nov; 64(11):723-8. PubMed ID: 4089703
[No Abstract] [Full Text] [Related]
19. Experience with flutamide in previously untreated patients with advanced prostatic cancer.
Sogani PC; Whitmore WF
J Urol; 1979 Nov; 122(5):640-3. PubMed ID: 501817
[TBL] [Abstract][Full Text] [Related]
20. [Use of flutamide in the treatment of carcinoma of the prostate stages C and D (T3-T4, Nx-N0, M0-M1 categories)].
Daricello G; Caramia G; Rizzo FP; Serretta V; Di Trapani D; Pavone-Macaluso M
Minerva Urol Nefrol; 1986; 38(1):71-6. PubMed ID: 3738681
[No Abstract] [Full Text] [Related]
[Next] [New Search]
